STOCK TITAN

Insider sales at XNCR (NASDAQ: XNCR) show 73,367-share transaction

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

XNCR insider filing reports sales of company common stock by John Desjarlais. The filing lists securities to be sold: 2,502 common shares tied to restricted stock vesting on 03/05/2026 as compensation. It also discloses three reported sales during the past three months: 73,367 shares on 12/19/2025 for $11,534,819.99, 2,663 shares on 03/03/2026 for $31,676.65, and 4,118 shares on 03/05/2026 for $46,308.97.

Positive

  • None.

Negative

  • None.

Insights

Filing records multiple insider sales and a small vesting-related sale.

John Desjarlais reports sales of common stock in several transactions, including a large sale of 73,367 shares on 12/19/2025 and smaller sales on 03/03/2026 and 03/05/2026. The filing also lists 2,502 shares tied to restricted stock vesting on 03/05/2026.

Cash‑flow recipients and further context for the large December sale are not detailed in the excerpt; subsequent filings would show additional attribution or footnotes if present.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the XNCR Form 144 report about insider sales?

The filing reports insider sales of common stock by John Desjarlais, including a sale of 73,367 shares. It also lists sales of 2,663 and 4,118 shares and a planned sale of 2,502 vested restricted shares on 03/05/2026.

How many shares were tied to restricted stock vesting in the XNCR filing?

The filing shows 2,502 common shares tied to restricted stock vesting on 03/05/2026. Those shares are labeled as compensation and are identified as securities to be sold by the filer.

What dollar amounts are shown for the recent XNCR insider sales?

The excerpt lists proceeds of $11,534,819.99 for 73,367 shares on 12/19/2025, $31,676.65 for 2,663 shares on 03/03/2026, and $46,308.97 for 4,118 shares on 03/05/2026.

Who acted as broker for the transactions in the XNCR filing?

The filing identifies Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI, as the broker associated with the securities transactions listed in the excerpt.

Does the XNCR excerpt explain why the large December sale occurred?

No, the excerpt provides transaction dates, share counts, and dollar amounts but does not supply a reason for the December sale or detail cash‑flow recipients beyond broker identification.
Xencor

NASDAQ:XNCR

XNCR Rankings

XNCR Latest News

XNCR Latest SEC Filings

XNCR Stock Data

818.46M
70.35M
Biotechnology
Pharmaceutical Preparations
Link
United States
PASADENA